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In this report, an antisense RNA strategy has allowed us to show that disruption of ALP expression affects the expression 
of the muscle transcription factors myogenin and MyoD, resulting in the inhibition of muscle differentiation. Introduc­
tion of a MyoD expression construct into ALP-antisense cells is sufficient to restore the capacity of the cells to differentiate, 
illustrating that ALP function occurs upstream of MyoD. It is known that MyoD is under the control of serum response 
factor (SRF), a transcriptional regulator whose activity is modulated by actin dynamics. A dramatic reduction of actin 
filament bundles is observed in ALP-antisense cells and treatment of these cells with the actin-stabilizing drug jas- 
plakinolide stimulates SRF activity and restores the capacity of the cells to differentiate. Furthermore, we show that 
modulation of ALP expression influences SRF activity, the level of its coactivator, MAL, and muscle differentiation. 
Collectively, these results suggest a critical role of ALP on muscle differentiation, likely via cytoskeletal regulation of SRF.
INTRODUCTION
Development of skeletal muscle cells is characterized by a 
succession of events starting with the determination of me­
sodermal progenitor cells into muscle precursor cells called 
myoblasts. Later, upon induction of muscle differentiation, 
proliferating myoblasts withdraw from the cell cycle, align, 
and fuse to become multinucleate myotubes that will mature 
into functional myofibers (for review, see Olson, 1992). 
These morphological changes are accompanied by the up- 
regulation of muscle-specific genes, including those encod­
ing members of the myogenic regulatory factor (MRF) fam­
ily of basic helix-loop-helix transcription factors and the 
myocyte enhancer factor-2 (MEF-2). The MRF family, com­
prised of MyoD, Myf5, myogenin, and myogenic regulatory 
factor 4 (MRF4), regulates the transcription of genes neces­
sary for the specification of myoblasts from somatic meso­
derm and subsequently for their differentiation into contrac­
tile muscle cells. MEF-2 collaborates with MRFs to regulate 
muscle-specific gene expression required for terminal differ­
entiation (for review, see Ludolph and Konieczny, 1995).
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The earliest steps in skeletal muscle differentiation involve 
the formation and maintenance of myoblasts and are con­
trolled by MyoD and Myf5 (for review, see Weintraub, 
1993). Knowledge of how these key muscle determination 
factors are controlled is thus pivotal for understanding how 
muscle is formed during development. The demonstration 
that Myf5 and MyoD modulate different pathways of muscle 
development (Megeney et ah, 1996; Tajbakhsh et ah, 1996) 
and display distinct spatiotemporal expression patterns 
(Cossu et ah, 1996) suggested that these two myogenic fac­
tors might be activated by different upstream signaling path­
ways. Indeed, it is now recognized that various hormones 
and growth factors differentially influence MyoD and Myf5 
expression (Carnac et al., 1992; Cossu et al., 1996; Montarras 
et ah, 1996). Moreover, it has been demonstrated that serum 
response factor (SRF), a MADS box transcription factor es­
sential for muscle differentiation (Arsenian et al., 1998), reg­
ulates MyoD, but not Myf5, gene expression in myoblasts 
(Carnac et al., 1998) through a functional SRF-binding CarG 
element present in the distal regulatory region of the MyoD 
gene (L'Honore et al., 2003), providing molecular insight into 
one mechanism by which MRFs are differentially controlled.
SRF regulates both cellular immediate-early genes such as 
c-fos as well as a variety of muscle-specific genes (Johansen 
and Pry wes, 1995; Treisman, 1995; Arsenian et ah, 1998). As 
occurs with many transcriptional regulators, SRF interacts 
with a variety of other factors to control tissue-specific gene 
expression (Treisman, 1994; Wang and Olson, 2004). SRF 
and its partners are themselves influenced by a variety of 
intracellular signals. In the case of SRF-dependent transcrip­
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tion of the c-fos gene, the critical SRF partner, TCF (ternary 
complex factor), is regulated by MAP kinase-dependent 
phosphorylation (Treisman, 1994). Alternatively, SRF-de- 
pendent regulation of some genes can be influenced by 
changes in actin dynamics, independent of known MAP 
kinase signaling pathways. In this case, which has been 
well-documented in fibroblasts, SRF-dependent transcrip­
tional activity is positively regulated through Rho-stimu- 
lated increases in actin polymerization and stabilization 
(Sotiropoulos et ah, 1999), which induce the cytoplasmic-to- 
nuclear redistribution of MAL, a recently identified SRF 
coactivator (Miralles et ah, 2003). It is postulated that MAL's 
accumulation in the nucleus is inhibited by direct binding of 
G-actin that occurs when monomeric actin levels are ele­
vated. Furthermore, the two actin-depolymerizing agents, 
latrunculin B and cytochalasin D, which have opposing 
effects on SRF activity (Geneste et ah, 2002), also exhibit 
differential effects on MyoD expression (Dhawan and Helfman, 
2004) in accordance with the view that actin dynamics affect 
MyoD expression through SRF activity. RhoA can also stim­
ulate SRF-dependent expression of muscle-specific genes 
(Carnac et ah, 1998; Wei et ah, 1998); thus this, or a similar, 
mechanism may be relevant in muscle cells as well.
The link between actin dynamics and transcriptional con­
trol illustrates an exciting point of convergence between 
cytoarchitecture and nuclear function. Recently, certain pro­
teins that regulate actin assembly state have been shown to 
influence SRF-dependent transcription, providing a more 
detailed picture of how this interplay might be achieved in 
vivo. For example, overexpression of LIM kinase, which 
phosphorylates and inactivates the actin disassembly factor, 
cofilin, enhances actin stability and activates SRF (Sotiropoulos 
et ah, 1999; Geneste et ah, 2002). Likewise, expression of 
inactive VASP mutants disturbs both actin assembly within 
cells and abrogates SRF activation (Grosse et ah, 2003). The 
exquisite sensitivity of SRF activation state to the dynamics 
and organization of the actin cytoskeleton highlights the 
potential importance of cytoskeletal factors in the regulation 
of gene expression.
We have recently purified and characterized a PDZ-LIM 
protein called the a-actinin associated LIM protein (ALP), 
which displays dramatically upregulation during muscle 
differentiation (Pomies et ah, 1999). ALP is expressed in 
smooth, cardiac, and skeletal muscle cells (Pomies et ah, 
1999; Xia et ah, 1997). Two ALP isoforms which exhibit 
identical N-terminal PDZ domains and C-terminal LIM do­
mains with a variable central core are produced as a result of 
alternative splicing (Pomies et ah, 1999). As its name implies, 
ALP interacts directly with the actin-binding protein a-acti- 
nin and is colocalized with a-actinin at the Z-discs of striated 
muscle cells (Xia et ah, 1997; Pomies et ah, 1999). The a-acti- 
nin binding capacity of ALP maps to the N-terminal PDZ 
domain and both ALP isoforms interact with a-actinin (Xia 
et ah, 1997; Pomies et ah, 1999). Biochemical studies revealed 
that purified ALP enhances a-actinin's capacity to cross-link 
actin filaments, raising the possibility that ALP plays a role 
in actin organization and anchorage within muscle cells 
(Pashmforoush et ah, 2001). Indeed, overexpression of ALP 
induces the assembly of highly organized, robust actin ar­
rays (Pashmforoush et ah, 2001). The regulated expression of 
ALP during muscle differentiation coupled with its capacity 
to enhance cytoskeletal organization led us to explore its role 
during differentiation of cultured C2C12 myoblasts.
Here we report that differentiation of C2C12 myoblasts is 
accompanied by a dramatic increase in expression and 
switching of ALP isoforms. Antisense-mediated down-reg- 
ulation of ALP expression in C2C12 myoblasts interferes
with the differentiation response. Knock-down of ALP ex­
pression results in failure in the expression of the critical 
myogenic transcription factors, myogenin and MyoD, but 
not Myf5. Reintroduction of MyoD restores the capacity of 
the cells to differentiate, indicating that ALP functions up­
stream of MyoD. As discussed above, MyoD expression is 
regulated by SRF, a transcription factor whose activity can 
depend on actin filament organization. Loss of ALP function 
leads to a dramatic reduction in actin filament arrays in 
C2C12 myoblasts, a decrease in levels of the SRF coactivator, 
MAL, and a concomitant reduction in SRF activity. Induc­
tion of actin filament assembly and stabilization by jas- 
plakinolide restores the capacity of C2C12 cells to fully 
differentiate in absence of ALP. Finally, we show that over­
expression of ALP in C2C12 cells grown in proliferation 
medium induces differentiation of C2C12 cells, accompanied 
by an increase of SRF activity. Our results thus suggest a 
critical role for ALP in the integration of cytoskeletal archi­
tecture and transcriptional regulation that is essential for 
myogenic differentiation of C2C12 myoblasts.
MATERIALS AND METHODS
Gel Electrophoresis and Western Immunoblotting
Protein fractions were separated by SDS-PAGE according to the method of 
Laemmli (1970) except with a bisacrylamide concentration of 0.13%. 12.5% or 
8% polyacrylamide gels were used in this work.
For Western immunoblotting, proteins were resolved by SDS-PAGE and 
transferred to nitrocellulose. Rabbit polyclonal antibodies raised against 
chicken ALP isoforms (K55; Pomies et at, 1999), Myf5 (Santa Cruz Biotech­
nology, Santa Cruz, CA), MyoD (Santa Cruz Biotechnology), SRF (Santa Cruz 
Biotechnology), MRTF-A/MAL (Santa Cruz Biotechnology), GFP (Torrey 
Pines Biolabs, Houston, TX), and actin (Sigma, Saint Louis, MO) were used, 
followed by horseradish peroxidase linked to protein A (Amersham Life 
Science, Cleveland, OH). A goat polyclonal antibody directed against MRTF- 
A/MAL (Santa Cruz Biotechnology) was also used, followed by horseradish 
peroxidase linked to rabbit antibodies anti-goat immunoglobulins (Dako, 
Copenhagen, Denmark). Monoclonal antibodies specific for skeletal myosin 
heavy chain (Sigma), nonmuscle a-actinin (ICN Biomedicals, Aurora, OH), 
sarcomeric a-actinin (Sigma), myogenin (PharMingen, San Diego, CA), and 
a-tubulin (Monosan, Uden, The Netherlands) were used, followed by horse­
radish peroxidase linked to whole sheep antibody directed against mouse 
immunoglobulins (Amersham Life Science, Piscataway, NJ). Immunodetec­
tion was enhanced using chemiluminescent techniques (ECL, Amersham Life 
Science).
Cell Culture and Microscopy
The C2C12 myogenic cell line was grown in DMEM supplemented with 10% 
fetal bovine serum (growth medium). C2C12 differentiation was induced by 
transferring the cells into DMEM supplemented with 2% horse serum (dif­
ferentiation medium).
Phase contrast images of living cells were collected on an inverted Nikon 
Eclipse TE300 microscope (Melville, NY) and analyzed using the QED imag­
ing software (QED Imaging, Pittsburgh, PA).
Indirect immunofluorescence of C2C12 cells was performed as described 
previously by Arber et a l  (1994). C2C12 cells were cultured on glass coverslips 
in growth medium and were induced to differentiate by transferring the cells 
in differentiation medium. For immunostaining, the polyclonal antibody 
raised against ALP (K55) and the mAb specific for sarcomeric a-actinin 
(Sigma) were used. They were followed by a FITC-conjugated goat anti-rabbit 
secondary antibody (Molecular Probes, Eugene, OR) and a Texas Red-con­
jugated goat anti-mouse secondary antibody (Molecular Probes). Staining of 
the nuclei was obtained using Hoechst 33258 (Sigma), and staining of the actin 
bundles was obtained using phalloidin-TRITC (Sigma). Images of the cells 
were collected on a Zeiss Axiophot microscope (Thomwood, NY) and ana­
lyzed using the Openlab software (Improvision, Lexington, MA).
Construction o f the ALP-Antisense Expression Vector and 
Establishment o f Stable C2C12 Cells Lines Harboring 
ALP-Antisense Transcripts
The full-length rat skALP was cloned in the antisense orientation into the 
pcDNA3.1 expression vector (Invitrogen, Carlsbad, CA) via the EcoRV and 
Notl sites.
C2C12 cells were transfected with the ALP-antisense vector or the empty 
pcDNA3.1 expression vector using the transfection reagent Lipofectamine
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(GIBCO BRL, Grand Island, NY). In brief, C2C12 cells were maintained in 
growth medium until they reached 70% confluence. For transfection, 6 /xg of 
either ALP-antisense vector or empty pcDNA3.1 vector were mixed with 
Lipofectamine in serum-free DMEM for 45 min and added to the C2C12 cells 
placed in serum-free DMEM. Transfection was carried out for 12 h  at 37°C. 
Forty-eight hours after transfection the C2C12 cells were grown in growth 
medium containing the neomycin analogue G418 (GIBCO BRL) to enable 
selection of stably transfected cells. Individual clones were isolated using 
cloning rings and were further grown in growth medium supplemented with 
G418.
RT-PCR Amplification o f  Mouse cDNA Fragments
Total RNA was isolated from ALP-antisense C2C12 cells (clone Anti 141) and 
control C2C12 cells (clone Vector 13G) cultured in growth medium using the 
Mini RNA Isolation II kit (Zymo Research, Orange, CA). First-strand cDNA 
was synthesized with 0.5 /xg of total RNA from ALP-antisense cells and 
control cells in a final volume of 30 /x 1, and PCR was then used to assess 
expression of mouse Myf5, MyoD, and smooth muscle ALP (smALP). The 
following sequences of forward and reverse primers were used: Myf5, 5 '- 
CACCATGCGCGAGCGTAGA-3' and 5'-TCTGTCCCGGCAGGCTGTAA-3'; 
MyoD, 5'-GGAAGAGTGCGGCTGTGT-3' and 5'-CTGTTCTGTGTCGCT- 
TAGGG-3'; smALP, 5 '-ATGCCCC AG A ACGTAGTTCTC-3' and 5'-AGCTTT- 
GGGGTACAGAGTGAC-3'. As an internal control, PCR was also performed 
in parallel using primers for mouse tubulin.
Transfection o f  ALP-Antisense C2C12 Cells ivith a 
pcDNA3IMyoD Construct
ALP-antisense C2C12 cells (clone Anti 141) were transiently transfected with
3 /xg of either the pcDNA3 expression vector alone or a pcDNA3/MyoD 
construct using Lipofectamine PLUS reagent (GIBCO BRL). Transfection was 
carried out for 6 h  at 37°C. The cells were then grown in proliferation medium 
for 36 h before induction of differentiation.
Figure 1. Expression of muscle-specific markers during differen­
tiation of C2C12 cells. Phase contrast images of C2C12 cells grown 
in proliferation medium (A) and placed in differentiation-promoting 
conditions for 8 d (B). Different muscle markers were detected by 
Western immunoblotting in proliferating (dO) as well as in differ­
entiating C2C12 cells, 2 d (d2), 5 d (d5), and 8 d (d8) after inducing 
differentiation: (C) myogenin; (D) a-actinin 2; (E) myosin; and (F) 
the 2 ALP isoforms, skALP and smALP.
Generation o f  ALP-Antisense Adenoviral Vectors and 
Adenoviral Infection o f  C2C12 Cells
Adenoviral vectors were generated according to protocols previously de­
scribed (Wang et at, 1996). In summary, mouse smALP cDNA was cloned 
downstream of the cytomegalovirus (CMV) promoter of the pXCJL.l shuttle 
plasmid in the antisense orientation. A full-length smALP cDNA, a 262-base 
pair fragment of the 5 ' region of ALP containing the PDZ domain, and a 
284-base pair fragment of the 3 ' region containing the LIM domain sequences 
were used to generate the antisense shuttle plasmids. The adenoviral vectors 
were then generated through homologous recombination between pJM17 
plasmid and the shuttle plasmids in 293 cells as previously described. The 
orientation of the ALP sequences with respect to the CMV promoter was 
confirmed by PCR analysis of the viral DNA. The viral vector Ad/ALP/as 
contains the full-length smALP, Ad/ALP-PDZ/as contains the PDZ domain 
sequences, and Ad/ALP-LIM/as contains the LIM domain sequences in an 
antisense orientation with respect to the CMV promoter.
C2C12 cells were infected with 20 -30  PFUs (plaque forming units) for 12 h 
while growing in growth medium and then transferred to differentiation 
medium to induce myogenic differentiation. After 5 d in differentiation me­
dium, cells were assayed for differentiation of myoblasts to myotubes by 
Western immunoblot and indirect immunofluorescence.
fasplakinolide Treatment
ALP-antisense C2C12 cells were placed in differentiation medium in absence 
or in presence of 0.16 /xM jasplakinolide (Calbiochem, Darmstadt, Germany) 
for 1 h. After treatment, the cells were washed once and then grown in 
differentiation-promoting conditions for 7 d.
SRF Reporter Assay
For luciferase assays, proliferating ALP-antisense C2C12 cells (clone Anti 141), 
control C2C12 cells (clone Mock 13G) or C2C12 cells were cotransfected with
2 /xg of the SRF reporter plasmid pSRE3~Luc, which contains a luciferase 
cDNA controlled by 3 SRF binding sites, and 40 ng of a Renilla standardiza­
tion reporter plasmid, used as an internal transfection control to normalize 
luciferase reporter activity. In some experiments, C2C12 cells were cotrans­
fected with 2 /xg of either the expression vector pQE-TriSystem (QIAGEN, 
Valencia, CA) encoding mouse smALP or the empty pQE-TriSystem vector. 
Cells were then placed in differentiation-promoting conditions for 2  d before 
quantitation of reporter activity. In other experiments, C2C12 cells were 
cotransfected with 2  /xg of either the expression vector pEGFP-Nl (Clontech, 
Mountain View, C A) encoding mouse sm ALP or the empty pEGFP-Nl vector. 
Cells were then placed in growth medium for 5 d before analysis.
RESULTS
Induction o f  ALP Expression during Myogenic 
Differentiation
To examine the potential role of ALP in muscle cytoarchi- 
tecture and function, we have used the myogenic C2C12 cell 
line, a well-established model for testing the role of muscle 
proteins in differentiation and contractile function (Arber et 
ah, 1994; Ornatsky et ah, 1997). C2C12 myoblasts proliferate 
in presence of high concentration of serum and are induced 
to differentiate into functional myotubes upon removal of 
growth factors. As differentiation proceeds, the cells elon­
gate, fuse, and develop contractile properties (Figure 1, A 
and B). The induction of differentiation can also be moni­
tored biochemically (Figure 1, C-F). Within 2 d of growth 
factor removal, expression of the myogenic transcription 
factor, myogenin, is evident (Figure 1C). The increase in 
myogenin is transient and by day 5, the protein levels have 
already declined significantly relative to the earlier peak 
expression. Muscle-specific markers of the contractile ma­
chinery such as a-actinin-2 and muscle myosin heavy chain 
are absent in undifferentiated cells, but are induced during 
the differentiation process and remain at high levels (Figure
1, D and E).
The expression of ALP isoforms is also regulated in re­
sponse to differentiation cues. In proliferating C2C12 cells, 
the lower molecular mass isoform, referred to as smALP 
based on its prominence in cardiac and smooth muscle cells 
(Pomies et ah, 1999), is expressed at a low level, whereas the 
higher molecular mass isoform, referred to as skeletal mus­
cle ALP (skALP), based on its strong expression in differen­
tiated skeletal muscle, is not detected (Figure IF). The ex­
pression of smALP in proliferating myoblasts highlights its 
potential role before induction of terminal differentiation. 
Similar to what is observed for myogenin, the expression of 
smALP increases dramatically 2 d after induction of differ­
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entiation and then declines, a pattern that suggests a role for 
smALP during the early stages of myogenesis (Figure 1, C 
and F). In contrast, skALP expression increases, progres­
sively mirroring what occurs for the late myogenic differen­
tiation marker, myosin (Figure 1, E and F).
Disruption o f  ALP Expression Inhibits Muscle Cell 
Differentiation
The finding that smALP expression is up-regulated upon 
induction of differentiation raised the possibility that 
smALP plays an important role during the early stages of 
skeletal muscle differentiation. To examine this possibility, 
we have transfected the C2C12 cell line with a mammalian 
expression vector containing the full-length skALP cDNA in 
the antisense orientation. This construct would be expected 
to lead to reduction in both smALP and skALP expressions 
because these are encoded by alternatively spliced tran­
scripts that have much sequence in common (Pomies et al., 
1999). Stably transfected C2C12 clones were screened by 
examining the levels of smALP and skALP expression rela­
tive to C2C12 clones transfected with an empty vector. Three 
antisense clones and one empty vector clone were selected 
for further characterization. These C2C12 clones were main­
tained in growth medium and then induced to differentiate 
by transfer into differentiation medium. Examination of an­
tisense cells maintained in growth medium revealed elimi­
nation of smALP expression compared with vector controls 
(Figure 2A). After 5 d in differentiation-promoting condi­
tions, the three antisense clones display dramatically de­
creased smALP and skALP expression relative to the control 
vector clone, which shows the typical increase in both 
smALP and skALP levels (Figure 2A). By densitometric 
analysis of the bands detected by Western immunoblot, 
smALP is undetectable in all three antisense clones. skALP 
expression is also consistently reduced although we ob­
served variable extents of remaining skALP, from 8 to 52%, 
depending on the clone analyzed (Figure 2B).
Antisense inhibition of ALP expression does not affect cell 
viability, and no gross morphological differences are de­
tected between control transfectants and the three antisense 
cell lines (Figure 2, C-F). However, a striking difference in 
cell behavior is observed when a muscle differentiation sig­
nal is applied. In contrast with vector-transfected cells, 
which establish elongated large myotubes after 5 d of induc­
tion of differentiation, ALP-antisense C2C12 cells retain a 
fibroblast-like shape typical of proliferating myoblasts (Fig­
ure 2, G-J).
To confirm that the muscle differentiation program is inhib­
ited in ALP-antisense C2C12 cells, we evaluated the expression 
levels of three muscle differentiation markers, a-actinin 2, my­
osin, and myogenin, in the three ALP-antisense clones. In 
contrast with the control transfectant in which all three differ­
entiation markers display elevated expression after 5 d in dif­
ferentiation medium, only a very minimal induction of differ­
entiation markers is observed in the antisense cell lines (Figure
2, K-N). Importantly, the expression of the nonmuscle isoform 
of a-actinin (Figure 2N) and a-tubulin (data not shown) is 
unaffected in antisense clones, suggesting that targeting ALP 
expression specifically affects the production of muscle-specific 
proteins. Consistent with the biochemical analysis, neither 
myogenin nor sarcomeric a-actinin are detected by indirect 
immunofluorescence of the ALP-antisense 141 cells grown in 
differentiation medium for 5 d (data not shown). Taken to­
gether, these results demonstrate that the differentiation pro­
cess is severely affected in C2C12 myoblasts in which ALP 
expression is perturbed. The loss of myogenin expression in 
ALP-antisense C2C12 cells placed in differentiation-promoting
Figure 2. ALP-antisense C2C12 clones fail to differentiate when 
placed in differentiation-promoting conditions. Expression levels of 
smALP and skALP were analyzed in 3 ALP-antisense clones (Anti­
sense 131, 141 and 151) and in 1 empty vector clone (Vector 13G). (A) 
smALP and skALP were detected by Western immunoblotting in 
proliferating cells (day 0) and in cells placed in differentiation medium 
for 5 d (day 5). (B) Densitometric analysis of the bands detected by 
Western immunoblotting at day 5 in differentiation medium. The data 
are expressed as a percentage of the maximum protein expression 
detected for the Vector 13G clone. This graph represent the densito­
metric analysis of the autoradiography shown in A, representative 
itself of five different autoradiographies. (C-J) Phase contrast pictures 
of the 3 ALP antisense clones (Antisense 131, 141 and 151) and the 
empty vector clone (Vector 13G). The cells were grown in proliferation 
medium (day 0) then placed in differentiation medium for 5 d (day 5). 
(K-N) Cell lysates were prepared from the 3 antisense clones (Anti­
sense 131,141 and 151) and the empty vector clone (Vector 13G) grown 
in proliferation medium (day 0) or placed in differentiation medium for
5 d (day 5). Expression of 3 different muscle-specific proteins was 
detected by Western immunoblotting: (K) a-actinin 2; (L) myosin; (M) 
myogenin. As a control, the nonmuscle isoform of a-actinin was de­
tected using the same technique (N).
conditions illustrates that the impact of loss of ALP on myo­
genesis occurs at an early stage in the muscle differentiation 
process.
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Figure 3. Expression of AI.P-PDZ- and AI.P-I.IM- 
antisense transcripts inhibits differentiation of 
C2C12 cells. (A) Generating Al.P-antisense tran­
scripts. A full-length smAI.P cDNA was cloned in 
the antisense orientation with respect to the CMV 
promoter to generate the Ad/AI.P/as virus. The 
Ad/AI.P-PDZ/as and Ad/AI.P-IJM/as adenovi­
ruses contain the PDZ and I.IM domain, respec­
tively, in the antisense orientation. (B) C2C12 cells 
were infected with Al.P-antisense, AI.P-PDZ-anti- 
sense and AI.P-I.IM-antisense adenoviruses and 
then allowed to differentiate in differentiation me­
dium for 5 d. Expression of the three antisense tran­
scripts results in loss of skAI.P expression (AI.P) and 
in marked reduction of sarcomeric n-actinin expres­
sion (n-actinin 2) whereas the nonmuscle isoform 
remained unchanged (nonmuscle n-actinin). The 
control adenovirus Ad/|3-ga! expressing the |3-ga- 
lactosidase gene had no effect on n-actinin 2 expres­
sion. (C) Panels a -f show light microscopy and a '-f ' 
show the corresponding n-actinin 2 immunostaining 
of the infected cells. Panels a and a ', undifferentiated 
mock infected cells; b and b ', differentiated mock 
infected cells; c and c', Ad/AI.P-PDZ/as infected 
cells; d and d', Ad/AI.P-I.IM/as infected cells; eand 
e ', Ad/AI.P/as infected cells; f and f', Ad/|3-ga! 
infected cells. AH adenoviral-infected cells were 
maintained in differentiation medium for 5 d.
Several PDZ-LIM proteins related to ALP, including CLP- 
36/hCLIM1, Enigma, ENH, and Cypher/ZASP, are also 
expressed in striated muscle cells (Kuroda et ah, 1996; Guy et 
al., 1999; Kotaka et al., 1999; Zhou et al., 1999). Therefore, to 
confirm the specificity of the ALP-antisense targeting con­
struct, we have first determined the expression levels of two 
ALP-family members, Cypher 1 and CLP-36, in ALP-anti- 
sense C2C12 cells. We have observed that Cypher 1 is only 
expressed in differentiated C2C12 cells (data not shown). In 
accordance with its exclusive expression in differentiated 
C2C12 cells and with the fact that ALP-antisense C2C12 cells 
are unable to enter the differentiation program, we did not 
detect Cypher 1 expression in ALP-antisense cells (data not 
shown). We have also observed that CLP-36 expression is 
not significantly affected in ALP-antisense cells compared 
with control C2C12 cells (data not shown). Furthermore, we 
have generated two more specific antisense constructs cor­
responding to the PDZ domain and the LIM domain of ALP 
(Figure 3A). As we observed for full-length ALP-antisense, 
the expression of ALP-PDZ- and ALP-LIM-antisense RNAs 
totally abolishes the expression of ALP in C2C12 cells grown 
for 5 d in differentiation medium (Figure 3B). Furthermore, 
a-actinin-2 expression is reduced in both PDZ-ALP- and 
LIM-ALP-antisense cells, suggesting that cell differentiation 
is affected (Figure 3B). Examination of cell morphology after 
stimulation of differentiation confirmed the effect of ALP 
antisense constructs on muscle differentiation. Control cells 
infected with an empty vector or with a vector containing 
the j3-galactosidase gene form myotubes and express a-ac­
tinin 2 when they are placed in differentiation-promoting 
conditions for 5 d. Unlike control cells, the PDZ-ALP- and 
LIM-ALP-antisense C2C12 cells do not form myotubes and
express very low levels of the muscle-specific protein, a-ac­
tinin 2 (Figure 3C). Taken together, these results demon­
strate the specificity of our ALP-antisense construct.
The MyoD Signaling Pathway Is Affected in 
ALP-Antisense C2C12 Cells
Myf5, MyoD, myogenin, and MRF4 are MRFs belonging 
to the basic helix-loop-helix protein family (Rudnicki and 
Jaenisch, 1995). Myogenin and MRF4 expression are required 
for fusion and terminal differentiation (Hinterberger et ah, 
1991; Venuti et ah, 1995). Myf5 and MyoD are expressed in 
proliferating C2C12 myoblasts and play critical roles in early 
muscle determination events, with Myf5 acting upstream of 
MyoD (Delfini et al., 2000; Hadchouel et al., 2003).
To determine whether the signaling pathways involving 
Myf5 or MyoD are affected in C2C12 cells lacking ALP 
expression, we evaluated the expression levels of these fac­
tors in ALP-antisense C2C12 cells. As shown in Figure 4A, 
Myf5 expression levels are not disrupted in the ALP-anti- 
sense cells. In contrast, MyoD expression is barely detectable 
in ALP-antisense C2C12 cells grown in proliferation me­
dium or placed in differentiation-promoting conditions for
2 d (Figure 4B), suggesting that MyoD expression or stability 
depends, either directly or indirectly, on the presence of 
ALP. Furthermore, analysis of transcript levels correspond­
ing to smALP, MyoD and Myf5 revealed that in ALP-anti- 
sense C2C12 cells, a decrease in the expression of ALP 
transcripts is accompanied with a reduction of MyoD, but 
not Myf5, transcripts (Figure 4C). These observations pro­
vide evidence that ALP acts either downstream of Myf5 or in 
a parallel pathway that regulates the transcription of MyoD.
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Figure 4. Alteration of the MyoD signaling pathway in AT.P-anti- 
sense C2C12 cells. Myf 5 (A) and MyoD (B) expression levels were 
detected by Western immunoblotting in AT.P-antisense C2C12 cells 
(Antisense 141) and control C2C12 cells (Vector 13G) grown in prolif­
eration medium (Day 0) or placed in differentiation-promoting condi­
tions for 2 d (Day 2). Unlike Myf5, MyoD expression is severely 
affected in AT.P-antisense C2C12 cells. (C), RT-PCR analysis of RNA 
from AT.P-antisense C2C12 cells (a) and control C2C12 cells (v) cul­
tured in growth medium was performed using primers corresponding 
to smAT.P, MyoD and Myf5. Tubulin served as a control. Representa­
tive expression patterns are shown. In AT.P-antisense C2C12 cells the 
level of MyoD transcripts is severely reduced. In a rescue experiment 
AT.P-antisense C2C12 cells were transfected with a MyoD construct 
(Anti14I/MyoD) or with an empty vector (Anti14I/pcDNA). Expres­
sion of muscle-specific proteins was detected by Western immunoblot­
ting: MyoD (D) in cells grown in proliferation medium for 36 h fol­
lowing transfection; myosin (F) and n-actinin 2 (F) in cells placed in 
differentiation-promoting conditions for 5 d. As a control, tubulin was 
detected in these cells using the same technique (G). Phase contrast 
images of the AT.P-antisense C2C12 cells transfected with the vector 
alone (H) or with the MyoD construct (I) and grown in differentiation- 
promoting conditions for 5 d.
To test whether the absence of differentiation observed in 
ALP-antisense C2C12 cells can be attributed to a decrease in 
MyoD activity, we introduced a MyoD expression construct 
into the ALP-antisense cells and tested their ability to un­
dergo differentiation in response to serum removal. In con­
trast with what we observe in ALP-antisense C2C12 cells, 
MyoD is detected in ALP-antisense cells transfected with the 
pcDNA3/MyoD construct (Figure 4D). Moreover, in ALP- 
antisense C2C12 cells programmed to express MyoD, ex­
pression of the muscle differentiation markers, myosin and 
a-actinin 2, is restored (Figure 4, E and F). Phase-contrast 
images show the presence of large myotubes in the ALP- 
antisense C2C12 cells transiently transfected with the MyoD 
construct (Figure 4, H and I). Thus, the reexpression of 
MyoD in the ALP-antisense cells is sufficient to restore the 
capacity of the cells to differentiate. This illustrates that the 
essential role of ALP in C2C12 muscle differentiation occurs 
upstream of MyoD.
Decreased Filamentous Actin in ALP-Antisense C2C12 
Cells
MyoD expression is controlled by SRF (Gauthier-Rouviere et 
al., 1996), a transcriptional regulator whose activity is mod­
ulated by actin dynamics (Sotiropoulos et ah, 1999). Stabili­
zation of filamentous actin is sufficient to promote the acti­
vation of SRF, leading to the expression of certain target 
genes (Sotiropoulos et ah, 1999), thus regulators of the actin 
cytoskeleton may impact SRF function. Recently, it has been 
shown that the F-actin-bundling protein Scpl reduces the 
rate of actin disassembly illustrating that actin cross-linking 
proteins can affect actin assembly dynamics in addition to 
affecting actin filament organization (Goodman et ah, 2003). 
We demonstrated previously that ALP facilitates a-actinin- 
dependent bundling of actin filaments in vitro and therefore 
could participate in the stabilization of cellular actin fila­
ments (Pashmforoush et ah, 2001). To examine whether actin 
filament arrays are affected in ALP-antisense cells, a fluores­
cent derivative of the F-actin-binding drug, phalloidin, was 
used to stain cells. As shown in Figure 5, A-C, a meshwork 
of actin bundles is present in control C2C12 myoblasts ex­
pressing ALP. In contrast, in C2C12 myoblasts lacking ALP 
expression, only few short bundles of actin filaments appear 
at the periphery of the cells (Figure 5, D-I), illustrating that 
loss of ALP expression leads to a reduction in actin bundles. 
This diminution of actin bundles in ALP-antisense C2C12 
cells is not due to a down-regulation of actin expression 
because the amount of total actin in the ALP-antisense cells 
are at least as high as that detected in control C2C12 cells 
(Figure 5, ] and K). Rather, the reduced phalloidin labeling 
in the ALP-antisense cells appears to reflect a shift in the 
organization or stability of cellular actin filaments when 
ALP is absent.
Differentiation o f the ALP-Antisense C2C12 Cells Is 
Induced by F-Actin Stabilization
It has been demonstrated that agents promoting F-actin 
accumulation and stabilization induce SRF activity. In par­
ticular, exposure of cells to the F-actin enhancing drug, 
jasplakinolide, has been shown to strongly activate SRF 
(Sotiropoulos et ah, 1999). To test whether actin stabilization 
could restore the differentiation capacity of the ALP-anti- 
sense cells, we have treated these cells with jasplakinolide. 
ALP-antisense C2C12 cells were placed in differentiation 
medium in presence of jasplakinolide for 1 h. This treatment 
was able to induce the formation of large F-actin aggregates 
in ALP-antisense C2C12 cells (Figure 6, A and B) as previ­
ously observed in REF52 cells (Bubb et ah, 2000). Using a SRF 
reporter assay described in Materials and Methods, we ob­
served that SRF activity is increased in the jasplakinolide- 
treated ALP-antisense cells (Figure 6C). Furthermore, al­
though the expression level of SRF did not vary, the
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Figure 5. Loss of actin bundles in ALP-antisense C2C12 cells. Immu­
nofluorescence microscopy of control Vector 13G C2C12 cells (A-C) 
and Antisense 141 C2C12 cells (D-F and G-I) grown in proliferation- 
promoting conditions. Cells were triple-labeled for ALP (A, D, and G), 
actin bundles (B, E, and H), and nuclei (C, F, and I). Only few short 
actin bundles are detected in ALP-antisense C2C12 cells. Total actin 
and tubulin were detected by Western immunoblotting in control 
C2C12 cells (Vector 13G) and ALP-antisense C2C12 cells (Antisense 
141) grown in proliferation medium. Bar, 30 jam.
expression level of the SRF cofactor, MAL, slightly increased 
after treatment (Figure 6, D-F). It has been demonstrated 
previously that MAL is a SRF coactivator making a link 
between actin dynamics and SRF transcriptional activity 
(Miralles et al., 2003). The jasplakinolide treatment was also 
able to induce MyoD expression when the ALP-antisense 
C2C12 cells were subsequently grown in differentiation- 
promoting conditions for 3 d (Figure 6, G and H). Further­
more, myosin expression (Figure 6, I and J) accompanied 
with myotube formation (Figure 6, K and L) was also in­
duced in ALP-antisense C2C12 cells placed in differentiation 
medium for 7 d after jasplakinolide treatment. These results 
demonstrated that jasplakinolide-induced stabilization of 
actin filaments is able to activate myogenic differentiation 
of the C2C12 cells in absence of ALP. Therefore, stabilization 
of actin filaments by the jasplakinolide drug is able to bypass 
the ALP requirement in the MyoD-dependent activation of 
myogenesis.
Activation o f SRF Is Modulated by ALP Expression 
Finally, in order to test whether ALP could play a role in 
MyoD regulation via cytoskeletal regulation of SRF activity, 
we used a SRF reporter assay in C2C12 cells overexpressing 
or lacking smALP. We first studied the activity of SRF in 
C2C12 cells transiently transfected with a vector encoding 
mouse smALP. Overexpression of smALP induced a 25%
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Figure 6. Differentiation of the ALP-antisense C2C12 cells after 
jasplakinolide treatment. ALP-antisense C2C12 cells were placed in 
differentiation-promoting conditions in absence or in presence of 
0.16 juM jasplakinolide for 1 h and then grown in differentiation 
medium for 1 d (A-F), 3 d (G and H) or 7 d (I-L). Fluorescence 
microscopy was performed to visualize F-actin in ALP-antisense 
C2C12 cells treated (B) or not (A) with jasplakinolide. SRF activity 
was determined in a similar experiment where the jasplakinolide- 
treated cells were previously cotransfected with the SRF reporter 
plasmid pSRE3-Luc and a Renilla standardization reporter plasmid 
(C). Luciferase activities are expressed after correction for Renilla 
reporter activities. Results are the mean ± SEM of three indepen­
dent experiments. Asterisks indicate statistical significance at p < 
0.003 according to the unpaired Student's t test. Cell lysates were 
analyzed by immunoblotting using SRF (D), MAL (E), MyoD (G), 
myosin (I) and tubulin (F, H, and J) antibodies. Phase contrast 
images of ALP-antisense C2C12 cells treated (L) or not (K) with 
jasplakinolide.
increase in SRF activity when the C2C12 cells were placed in 
differentiation medium for 2 d (Figure 7A). Under these 
conditions, SRF expression levels remained unchanged,
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Figure 7. SRF activities and MAL expression levels are dependent 
on ALP expression. C2C12 cells were cotransfected with a mouse 
smALP expression vector (pQE/smALP) or an empty vector (pQE), 
and the SRF reporter plasmid pSRE3-Luc associated with a Renilla 
standardization reporter plasmid, and were subsequently placed in 
differentiation medium for 2 d. SRF activity was determined in (A). 
In a similar experiment, expression levels of SRF (B), MAL (C), 
myosin (D), and tubulin (E) were analyzed by Western immuno­
blotting, while phase contrast images show the aspect of the C2C12 
cells transfected with the vector alone (F) or the smALP construct
(G) after 2 d in differentiation medium. (H) SRF activity was also 
determined in ALP-antisense C2C12 cells (Anti 141) or control 
C2C12 cells (Mock 13G) that were cotransfected with the SRF re­
porter plasmid pSRE3-Luc and a Renilla standardization reporter 
plasmid, and subsequently grown for 2 d in differentiation-promot­
ing conditions. Expression levels of SRF (I) and MAL (J) were 
detected by Western immunoblotting in ALP-antisense C2C12 cells 
(Anti 141) and control C2C12 cells (Mock 13G) grown in prolifera­
tion medium (Day 0) or placed in differentiation-promoting condi­
tions for 2 d (Day 2) and 5 d (Day 5). As a control, tubulin was 
detected under the same conditions (K). Luciferase activities are 
expressed after correction for Renilla reporter activities. Results are 
the mean ±  SEM of three independent experiments. Asterisks indi­
cate statistical significance at p < 0.003 according to the unpaired 
Student's t test.
whereas MAL expression increased somewhat (Figure 7, B 
and C). Furthermore, smALP overexpression stimulated dif­
ferentiation of the C2C12 cells, as can be seen by the en­
hanced myosin expression level (Figure 7D) and the en­
hanced formation of elongated C2C12 cells (Figure 6, F and
G). We next tested the activity of SRF in ALP-antisense 
C2C12 cells grown in differentiation-promoting conditions 
for 2 d. As shown in Figure 7H, activation of SRF was 
strongly reduced in ALP-antisense C2C12 cells compared 
with control C2C12 cells. Nevertheless, this diminution in 
SRF activity is not due to a loss of SRF expression because
Figure 8. SmALP overexpression induces differentiation of C2C12 
cells grown in proliferation conditions. C2C12 cells were cotrans­
fected with a smALP construct (pEGFP/smALP) or with an empty 
vector (pEGFP), and the SRF reporter plasmid pSRE3-Luc and a 
Renilla standardization reporter plasmid, and were subsequently 
grown under proliferation conditions for 5 d. Phase contrast images 
of the C2C12 cells transfected with the vector alone (A) or the 
smALP construct (B). Corresponding cell lysates were analyzed by 
immunoblotting using GFP (C), MyoD (D), a-actinin 2 (E), myosin 
(F), SRF (G), and tubulin (H) antibodies. (I) SRF activity was deter­
mined in these cells. Luciferase activities are expressed after correc­
tion for Renilla reporter activities. Results are the mean ± SEM of 
three independent experiments. Asterisks indicate statistical signif­
icance at p < 0.0005 according to the unpaired Student's t test. MAL 
expression levels (J) were also detected in the C2C12 cells trans­
fected with the vector alone (pEGFP) or the smALP construct 
(pEGFP/smALP) grown in proliferation medium for 3 d. As a 
control, tubulin was detected under the same conditions (K).
the amount of SRF is even slightly increased in ALP-anti­
sense cells compared with control C2C12 cells (Figure 71). In 
contrast with SRF, MAL expression levels are drastically 
reduced in the ALP-antisense cells (Figure 7J).
Because smALP overexpression was able to increase SRF 
activity in C2C12 cells placed in differentiation-promoting 
conditions (Figure 7A), we examined the effects of a similar 
overexpression on C2C12 cells grown in proliferation me­
dium. Unlike C2C12 cells transfected with the control vector, 
C2C12 cells expressing exogenous smALP (Figure 8C) form 
myotubes when grown under proliferation conditions for
5 d (Figure 8, A and B). Furthermore, all the myotubes 
formed under these conditions expressed the recombinant 
smALP/GFP protein as observed by direct fluorescence mi­
croscopy (data not shown). Differentiation is fully achieved 
in these cells since the muscle-specific markers MyoD, my­
osin and ai-actinin-2 are expressed under these conditions 
(Figure 8, D-F). Although SRF expression levels are similar
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in control and in sm ALP-overexpressingC2C12 cells (Figure 
8G), overexpression of smALP induces an increase of SRF 
activity accom panied by a small b u t reproducible increase in 
MAL expression when the cells were grown in proliferation 
m edium  (Figure 8, I-K). These results dem onstrated that 
overexpression of smALP stim ulates SRF activity and in­
duces differentiation of the C2C12 cell line even when the 
cells are grown under proliferation-prom oting conditions.
D IS C U S S IO N
Regulation o f ALP Expression and Isoform Diversity 
during Muscle Development
To gain insight into the role of ALP in muscle differentiation 
and organization, we studied ALP expression during  the 
differentiation process of the myogenic C2C12 cell line. We 
observed a striking regulation of ALP expression and iso­
form sw itching during  muscle cell differentiation. We show 
that the lower m olecular mass protein, smALP, is the only 
isoform expressed in proliferating C2C12 myoblasts, sug­
gesting that smALP plays a role before the induction of 
differentiation.
A striking up-regulation of smALP expression occurs in 
C2C12 cells placed in differentiation m edium . At later stages 
in the differentiation program , smALP expression declines 
and there is a corresponding increase in the expression of 
skALP. SkALP is the sole isoform present in m ature myo­
tubes w here it colocalizes at the Z-discs with its binding 
partner, a-actinin (Xia et al., 1997; Pomies et ah, 1999). The 
dram atic shift in ALP isoform expression during  muscle 
differentiation suggests that smALP and skALP have some 
unique properties that are functionally relevant at different 
stages of muscle developm ent. SmALP and skALP are en­
coded by a single gene and are generated as a result of 
alternative splicing. The m urine ALP isoforms display iden­
tical N- and C-term ini, including PDZ and LIM dom ains, 
and vary only in their central regions w here 63 am ino acids 
in smALP are replaced by 111 am ino acids in skALP. Thus 
far, no specific function has been assigned to this variable 
dom ain, which m ust be responsible for any nonoverlapping 
roles of smALP and skALP. Determ ination of the unique 
properties, and possibly protein partners, of smALP and 
skALP will likely provide valuable insight into the specific 
actions of these proteins at different stages in muscle differ­
entiation.
ALP-dependent Regulation o f the Myogenic Transcription 
Factor, MyoD
An antisense mRNA strategy has been used previously to 
assess the roles of a variety of proteins during  C2C12 differ­
entiation. The approach has enabled the identification of 
proteins involved at m ultiple stages in the differentiation 
process (Galbiati et ah, 1999; M ontanaro et ah, 1999; Chen et 
ah, 2000). U sing an antisense RNA approach, we have gen­
erated C2C12 cell clones in which smALP and skALP ex­
pression has been severely reduced. We find that ALP- 
antisense C2C12 cells are unable to differentiate when they 
are placed in differentiation-prom oting conditions. This dif­
ferentiation block is attributed to a specific effect on ALP 
transcripts because m ultiple antisense constructs that target 
different ALP sequences have com parable effects.
C om prom ised expression of ALP in C2C12 cells elimi­
nates the accum ulation of the myogenic transcription factors 
M yoD and m yogenin, as well as the expression of term inal 
differentiation m arkers such as skeletal m uscle myosin 
heavy chain, w ithout affecting Myf5 levels. M yoD is nor­
mally expressed in both determ ined, proliferating m yoblasts 
as well as differentiating muscle cells (M ontarras et ah, 1991), 
and M yoD levels are suppressed in both populations of cells 
when antisense-ALP is expressed. In myoblasts, M yoD plays 
an im portant role in controlling the proliferation-to-differ- 
entiation switch and at later stages in the differentiation 
process, M yoD regulates the expression of the essential ter­
minal differentiation factor, myogenin (for review, see Wein- 
traub, 1993). Thus, loss of M yoD expression is sufficient to 
explain the failure of antisense-ALP C2C12 cells to differen­
tiate. Indeed, restoration of M yoD expression is sufficient to 
bypass the requirem ent for ALP illustrating that ALP is an 
essential regulator of myogenesis that functions upstream  of 
M yoD in the differentiation pathw ay.
The C2C12 system provides an excellent model for assess­
ing the role of particular proteins in muscle differentiation 
b u t does not provide a high-resolution view of functional 
attributes of m ature myotubes. Consequently, it is possible 
that ALP also functions later in m ature m yotubes, perhaps 
in muscle hom eostasis or stress-induced hypertrophy. In 
this regard, it is interesting that M yoD has been implicated 
in the regulation of gene expression program s necessary for 
muscle m aintenance and repair (Lowe and Alway, 1999; 
Parker et al., 2003).
Role o f ALP in Muscle Development In Vivo 
In m ouse em bryos, ALP is expressed in precardial meso­
derm  and later is found in cardiac, skeletal, and smooth 
muscle (Pashm foroush et ah, 2001). Given the profound ef­
fects of abrogating ALP expression for the differentiation of 
C2C12 cells, one would anticipate that ALP deficiency 
would have serious deleterious consequences for muscle 
developm ent. Surprisingly, mice that lack ALP did not dis­
play a failure of skeletal muscle differentiation (Jo et ah, 
2001). H ow ever, hom ozygous m utation of the ALP gene 
resulted in m oderately penetran t (15%) em bryonic lethality 
that appears to result from heart failure (Pashm foroush et ah, 
2001). This phenotype depends on the genetic background, 
which may account for the lack of phenotype detected in 
skeletal muscle in the parallel study by Jo et al. (2001).
Analysis of mice in which the gene encoding ALP was 
disrupted by hom ologous recom bination revealed a role for 
ALP in the developm ent of cardiac muscle, in particular the 
right ventricular chamber. Loss of ALP resulted in em bry­
onic cham ber dysm orphogenesis, a failure of trabeculation, 
and cham ber dilation (Pashm foroush et ah, 2001). In surviv­
ing adults, cardiom yopathy resulted. Thus, ALP clearly con­
tributes to normal cardiac developm ent and function. The 
existence of m ultiple PDZ-LIM proteins closely related to 
ALP that are expressed in overlapping patterns with ALP 
(Kuroda et a l,  1996; Guy et a l,  1999; Kota ka e ta l ,  1999; Zhou 
et a l,  1999) may have provided som e com pensation for the 
lack of ALP and contributed to the muscle function in the 
ALP-deficient animals. Similarly, in skeletal muscle, it is 
well established that there are num erous signaling inputs 
that contribute to the upregulation of M yoD expression 
during  em bryogenesis, including som e that come from me­
soderm -adjacent structures like dorsal ectoderm  (Parker et 
a l,  2003). The complexity and plasticity of a three-dim en­
sional developing em bryo is m uch greater than can be 
achieved in cell culture models of differentiation. Thus, 
mechanism s for com pensatory signaling to abrogate the loss 
of ALP may occur within a developing organism that would 
not be possible in cell culture. Indeed, it is well established 
that elim ination of M yoD function in C2C12 cells blocks 
myogenic differentiation when this is not sufficient in the 
m ouse (Rudnicki et a l, 1992; Dedieu et a l,  2002).
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M echan ism  o f  A L P  Influence on SR F  A c tiv i ty  
We have show n that suppression of ALP levels leads to the 
loss of MyoD protein in C2C12 cells, thus providing evi­
dence that ALP influences the cellular levels of a m aster 
regulatory protein for m uscle differentiation. This regulation 
is likely to occur a t the level of transcription because MyoD 
transcripts are also reduced in the ALP-antisense cells. ALP 
may contribute to control M yoD expression by indirect ef­
fects on SRF activation state. It is now  well established that 
F-actin stabilization positively regulates SRF-dependent 
gene transcription, and depletion of the G-actin pool in 
the cells seems to be responsible for the activation of SRF 
(Sotiropoulos et a l, 1999). Thus, proteins that regulate the as­
sembly state of actin can influence SRF signaling (Sotiropoulos et 
al., 1999; Copeland and Treism an, 2002). ALP is localized 
along the actin filaments in proliferating C2C12 m yoblasts, 
and w e show ed previously that it enhances the ability of 
a-actinin to cross-link actin filaments in  vitro (Pashm foroush 
et ah, 2001). These observations suggest that ALP m ight 
participate in the stabilization of F-actin in m uscle cells, and 
w e report here that suppression of ALP expression gives rise 
to a reduction in F-actin arrays. Interestingly, the RIL protein 
that is closely related to ALP has been reported to m odulate 
the turnover of actin stress fibers (Vallenius et al., 2004), 
consistent w ith  the idea that ALP-related proteins have 
shared roles in regulation of actin dynamics. The properties 
of ALP suggest that it could im pact SRF-dependent m uscle 
gene transcription by virtue of its ability to stabilize F-actin. 
Several factors that influence the actin cytoskeleton and SRF 
activity, including LIM-kinase and VASP, have been identi­
fied by overexpression studies (Sotiropoulos et ah, 1999). The 
fact that w e observed deficits in actin organization and 
MyoD expression w hen ALP is com prom ised using a loss- 
of-function approach provides pow erful indication for a 
specific role of ALP in the cytoskeletal regulation of SRF. 
This hypothesis is strengthened by experim ents showing 
that overexpression of ALP stim ulates SRF activity, bu t not 
SRF expression, and that SRF activity, bu t not SRF expres­
sion level, is strongly reduced in ALP-antisense C2C12 cells. 
This variation of activity may result, a t least in part, from  a 
m odulation in the level of the SRF coactivator, MAL. SRF is 
postranslationally dow n-regulated by proteolytic degrada­
tion in NIH3T3 fibroblasts (Shin et ah, 2006), and it is possi­
ble that MAL stability m ay be influenced by actin m onom er 
or polym er. Im portantly, our ability to rescue m uscle differ­
entiation in the ALP-antisense cells by sim ple application of 
the actin stabilizing drug, jasplakinolide, illustrates that it is 
possible to bypass the requirem ent for ALP by m anipulating 
actin dynam ics. Actin dynam ics is know n to influence SRF 
via regulation of the nuclear accum ulation of MAL (Miralles 
et ah, 2003). O ur w ork raises the possibility that actin dy­
nam ics m ay also contribute to SRF activity by influencing 
MAL stability or expression. Future w ork will be required to 
define the detailed m olecular m echanism  by w hich ALP- 
induced changes in the actin cytoskeleton influence SRF 
function.
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